Election 2026 · Public beta

Independent, source-first accountability

TheStatedRecordFind a race
Back to the race record

Issue record

Health care and drug prices

In short

Janelle Stelson's campaign would let the government negotiate drug prices, ban surprise billing and take medical debt off credit reports. Scott Perry's campaign opposes a government-run system and backs pre-existing condition coverage, lower drug costs, bigger health savings accounts and buying insurance across state lines. Perry cosponsored pre-existing condition and insulin bills; none passed. He voted against three drug-cost bills that passed the House, including the Inflation Reduction Act, which also covered climate and taxes.

Campaign positions

What each campaign says.

Janelle Stelson

Would lower drug prices by letting the government negotiate them, ban surprise billing, and take medical debt off credit reports.

Scott Perry

Opposes a government-run system. Supports coverage of pre-existing conditions, lower drug costs, bigger health savings accounts and buying insurance across state lines.

Evidence timeline

What the record shows.

  1. official action

    Scott Perry: Matches stated direction

    He cosponsored pre-existing condition and insulin bills that did not pass, and voted against three drug-cost bills that passed the House, including the 2022 law.

    Read the full check

    Full detail

    His campaign says he supports reforms that keep coverage for pre-existing conditions and lower prescription drug costs. He cosponsored the Pre-existing Conditions Protection Act in 2019 and 2021, and a 2019 bipartisan bill to keep the FDA reviewing some pending insulin applications under the drug pathway. None passed. He voted against three health and drug-cost bills that passed the House: H.R. 3 in 2019, the 2022 Inflation Reduction Act, which let Medicare negotiate some drug prices and capped Medicare insulin costs, and the bipartisan Lower Costs, More Transparency Act in 2023. In 2017 he voted for the American Health Care Act, which would have let states allow insurers to price coverage by health status for some people with a gap in coverage. Limit: His cosponsored bills point the way he says, but none passed, and he voted against the drug-cost bills that did pass the House. The 2022 law also held climate and tax measures.

See something wrong or incomplete? Report it for review.

Sources12 source records

How we use sources

  1. Janelle Stelson for Congress, prioritieshttps://janellestelson.com/priorities/

    Friends of Janelle Stelson · Reviewed Oct 1, 2026

    Captured 2026-10-01; about 3,000 words under eleven headings. Much of it is about Perry, which is out of scope here.

    candidate statement

    For: Janelle Stelson: campaign position

  2. Patriots for Perry, issueshttps://patriotsforperry.com/issues/

    Patriots for Perry · Reviewed Oct 1, 2026

    Captured 2026-10-01; 1,060 words under twelve headings. Undated; several passages still refer to the Biden-Harris administration.

    candidate statement

    For: Scott Perry: campaign position; Scott Perry: Matches stated direction

  3. H.R. 892, Pre-existing Conditions Protection Act of 2021https://www.congress.gov/bill/117th-congress/house-bill/892

    Congress.gov · Reviewed Oct 1, 2026

    Sponsored by Rep. McMorris Rodgers. Perry was an original cosponsor on 2021-02-05, one of 56. He also cosponsored the 2019 version, H.R. 692, on 2019-04-01. Neither left committee.

    official legislative record

    For: Scott Perry: Matches stated direction

  4. H.R. 5444, Lower Insulin Costs Now Act (116th Congress)https://www.congress.gov/bill/116th-congress/house-bill/5444

    Congress.gov · Reviewed Oct 1, 2026

    Sponsored by Rep. Underwood (D-IL), introduced 2019-12-17 with Republican and Democratic original cosponsors, among them Rep. Guthrie and Rep. Kelly of Pennsylvania. Perry cosponsored it on 2019-12-23. Section 2 would have the FDA keep reviewing certain pending applications for biological products, insulin among them, under the drug-approval section (section 505) after March 23, 2020. Referred to committee; no further action.

    official legislative record

    For: Scott Perry: Matches stated direction

  5. H.R. 5444, as introducedhttps://www.govinfo.gov/content/pkg/BILLS-116hr5444ih/html/BILLS-116hr5444ih.htm

    U.S. Government Publishing Office · Reviewed Oct 1, 2026

    Lists the original cosponsors (Ms. Schakowsky, Mr. Guthrie, Mr. Kelly of Pennsylvania, Mr. Levin of Michigan) and says the Secretary shall continue to review such applications under section 505.

    official legislative record

    For: Scott Perry: Matches stated direction

  6. House roll call 682, 2019 (document)

    Office of the Clerk, U.S. House of Representatives · Reviewed Oct 1, 2026

    On passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, 2019-12-12. Passed 230-192. Perry (P000605) recorded Nay.

    official legislative record

    For: Scott Perry: Matches stated direction

  7. House roll call 420, 2022 (document)

    Office of the Clerk, U.S. House of Representatives · Reviewed Oct 1, 2026

    On the motion to concur in the Senate amendment to H.R. 5376, the Inflation Reduction Act, 2022-08-12. Passed 220-207. Perry (P000605) recorded Nay. Became Public Law 117-169.

    official legislative record

    For: Scott Perry: Matches stated direction

  8. Public Law 117-169 (the Inflation Reduction Act)https://www.govinfo.gov/content/pkg/PLAW-117publ169/html/PLAW-117publ169.htm

    U.S. Government Publishing Office · Reviewed Oct 1, 2026

    Section 11001 provides for Medicare negotiation of prices for certain high-priced drugs; section 11406 limits Medicare cost-sharing for covered insulin products.

    official legislative record

    For: Scott Perry: Matches stated direction

  9. House roll call 708, 2023 (document)

    Office of the Clerk, U.S. House of Representatives · Reviewed Oct 1, 2026

    On the motion to suspend the rules and pass, as amended, H.R. 5378, the Lower Costs, More Transparency Act, 2023-12-11. Passed 320-71. Perry (P000605) recorded Nay.

    official legislative record

    For: Scott Perry: Matches stated direction

  10. H.R. 5378, Lower Costs, More Transparency Act, as passed by the Househttps://www.govinfo.gov/content/pkg/BILLS-118hr5378eh/html/BILLS-118hr5378eh.htm

    U.S. Government Publishing Office · Reviewed Oct 1, 2026

    Title I is health care price transparency; Title II, 'Reducing health care costs for patients', includes generic-drug application transparency and limits on Medicaid spread pricing by pharmacy benefit managers.

    official legislative record

    For: Scott Perry: Matches stated direction

  11. House roll call 256, 2017 (document)

    Office of the Clerk, U.S. House of Representatives · Reviewed Oct 1, 2026

    On passage of H.R. 1628, the American Health Care Act of 2017, 2017-05-04. Passed 217-213. Perry (P000605) recorded Aye.

    official legislative record

    For: Scott Perry: Matches stated direction

  12. H.R. 1628, American Health Care Act of 2017, as passed by the Househttps://www.govinfo.gov/content/pkg/BILLS-115hr1628eh/html/BILLS-115hr1628eh.htm

    U.S. Government Publishing Office · Reviewed Oct 1, 2026

    Section 136 lets a state apply for waivers, including one under which insurers could price coverage by health status for some people who had a gap in coverage.

    official legislative record

    For: Scott Perry: Matches stated direction